Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: Analysis of STOMP and ORIOLE trials

Asian J Surg. 2023 May;46(5):2202. doi: 10.1016/j.asjsur.2022.11.099. Epub 2022 Dec 14.

Authors

Shangqi Cao¹, Xu Hu¹, Yanxiang Shao¹, Xiang Li²

Affiliations

¹ Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
² Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, PR China. Electronic address: hx_uro@sina.com.

PMID: 36526472
DOI: 10.1016/j.asjsur.2022.11.099

No abstract available

Publication types

Letter

MeSH terms

Humans
Male
Prostatic Neoplasms* / genetics
Prostatic Neoplasms* / pathology
Prostatic Neoplasms* / therapy
Radiosurgery*